Literature DB >> 3153775

ERCP in evaluating the mode of therapy in pancreatic pseudocyst.

I Nordback1, O Auvinen, I Airo, J Isolauri, O Teerenhovi.   

Abstract

Twenty patients with ultrasonographic or computed tomographic diagnosis of pancreatic pseudocyst were referred for endoscopic retrograde cholangiopancreatography (ERCP). Two of these were found at laparotomy not to have pseudocysts and were excluded. Pancreatography was successful in 15 out of 18 cases (83%) and cholangiography in 12 out of 18 cases (67%). Three types of pseudocysts were noticed according to the communication of the pseudocyst to the main pancreatic duct and the presence of pancreatic duct stenosis. Successful treatment included two spontaneous resolutions, two internal drainages and three left pancreatic resections. In the eight percutaneous external drainages four recurrences (50%) occurred, one after closure of temporary pancreatocutaneous fistula. All the recurrences occurred in Type III pseudocysts with communication of the pseudocysts to stenotic main pancreatic duct. In these cases internal drainage would have been the preferable treatment method. We believe that by ERCP one can identify pseudocysts not suitable for external drainage.

Entities:  

Mesh:

Year:  1988        PMID: 3153775      PMCID: PMC2423505          DOI: 10.1155/1988/47060

Source DB:  PubMed          Journal:  HPB Surg        ISSN: 0894-8569


  3 in total

Review 1.  Timing of intervention in acute pancreatitis.

Authors:  C D Johnson
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 2.  Pancreatic pseudocyst should be treated by surgical drainage.

Authors:  B Moran; D A Rew; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1994-01       Impact factor: 1.891

Review 3.  Role of pancreatography in the endoscopic management of encapsulated pancreatic collections - review and new proposed classification.

Authors:  Igor Mendonça Proença; Marcos Eduardo Lera Dos Santos; Diogo Turiani Hourneaux de Moura; Igor Braga Ribeiro; Sergio Eiji Matuguma; Spencer Cheng; Thomas R McCarty; Epifanio Silvino do Monte Junior; Paulo Sakai; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.